Sanofi SA

Type: Company
Name: Sanofi SA
Nationality: France
Web Address: http://en.sanofi.com/
First reported 14 hours ago - Updated 3 hours ago - 2 reports

Potential Sanofi (SNY) Trade Targets 2.62% Return

The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered-call trade on Sanofi-Aventis (SNY) that includes 4.05% downside protection. Sell one contract of the Dec. '14 ... [Published MarketIntelligenceCenter.com - 3 hours ago]
First reported 6 hours ago - Updated 6 hours ago - 3 reports

Research and Markets: Global Pediatric Vaccine Market 2014-2018: Key Vendors are GlaxoSmithKline, Merck, Pfizer and Sanofi

First reported Oct 30 2014 - Updated 7 hours ago - 19 reports

Smith & Nephew plc CEO Won't Comment On Sanofi CEO Job

October 30, 2014By Riley McDermid , BioSpace.com Breaking News StaffThe chief executive of biotech Smith & Nephew ( SNN ) has declined to comment on speculation that he is interested in taking the recently-vacated top spot at French drugmaker Sanofi ... [Published BioSpace - 20 hours ago]
First reported Oct 30 2014 - Updated 20 hours ago - 4 reports

Sanofi Beats on Q3 Earnings but Lantus Outlook Disappoints

Sanofi ’s ( SNY ) shares plunged almost 14.4% ever since it announced its third-quarter earnings on Oct 28. Although the earnings were above expectations, investors reacted negatively to the company’s announcement that one of its largest selling products, ... [Published Yahoo! Finance - 20 hours ago]
First reported 21 hours ago - Updated 20 hours ago - 3 reports

Aventis Systems Named 2014 Atlanta VMware User Group Partner of the Year

/PRNewswire/ -- Aventis Systems, Inc., a leading provider of both new and refurbished technology equipment, has been named Partner of the Year by the Atlanta VMware User Group (ATLVMUG).   Aventis Systems…Click to Continue » ... [Published Rock Hill Herald - 20 hours ago]
First reported Oct 30 2014 - Updated Oct 30 2014 - 3 reports

Sanofi : SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sanofi

NEW YORK, Oct. 30, 2014 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Sanofi. ("Sanofi" or the "Company") (NYSE: SNY -News). Such investors are ... [Published 4 Traders - Oct 30 2014]
First reported Oct 29 2014 - Updated Oct 30 2014 - 70 reports

Sanofi boss fired

Sanofi fired chief executive Chris Viehbacher, ending a six-year tenure in which he caused tension with board members.Read the full article here .This content was originally published by IoL Business Report . Original publishers retain all rights. It ... [Published Global Advisors - Oct 30 2014]
First reported Oct 29 2014 - Updated Oct 30 2014 - 9 reports

Sanofi SA Downgraded by Deutsche Bank (SNY)

Sanofi SA (NYSE:SNY)Shares of Sanofi SA (NYSE:SNY) traded down 5.93% on Wednesday, hitting $45.22. The stock had a trading volume of 16,821,976 shares. Sanofi SA has a one year low of $44.50 and a one year high of $57.42. The stock has a 50-day moving ... [Published American Banking News - Oct 30 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 6 reports

Sanofi's Zerhouni Said to Stay on After CEO's Ouster - Bloomberg

Sanofi's Zerhouni Said to Stay on After CEO's Ouster Bloomberg Besides Zerhouni, he hired Chief Financial Officer Jerome Contamine and Chief Strategy Officer David-Alexandre Gros. In a letter to Sanofi employees obtained by Bloomberg , Weinberg ... [Published Bloomberg via Google News - Oct 29 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 24 reports

Sanofi ousts chief executive

Lex discusses the turmoil at the French drugmaker“ ” is categorized as “business”. This video was licensed from Grab Networks. For additional video content, click the “video” tab at the top of this page. ... [Published American Banking News - Forex - Oct 29 2014]
Entities: Sanofi SA
First reported Oct 29 2014 - Updated Oct 29 2014 - 5 reports

Behind The Scenes Of Sanofi's Boardroom Bust Up

By Clip Syndicate A boardroom tussle brewing for months at Sanofi came to a head on Wednesday when France's top drugmaker fired its chief executive, wiping more billions off its share price. While the showdown played out in leaks to national newspapers ... [Published IT Business Net - Oct 29 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 5 reports

Statement from Sanofi Board of Directors

World News: 07:58 GMT Wednesday 29th October 2014 . [ ]This storyPARIS, Oct. 29, 2014 (GLOBE NEWSWIRE)The Board of Directors held a meeting Wednesday, October 29 at 8am and decided unanimously to remove Christopher A. Viehbacher as Chief Executive Officer ... [Published SPi World News - Oct 29 2014]

Quotes

...20. That loss in value couldn’t be excused by the firm and Ahn bowed out soon after, saying he had resigned "to pursue other long held personal and professional goals”—presumably ones that don’t involve the SEC and massive fines."
"The Appraisal Committee felt that dabigatran represents a potential benefit for many people who have had a DVT or PE, particularly those who have risk factors for recurrence of a blood clot and who therefore need longer term treatment. We are pleased, therefore, to be able to recommend dabigatran as a cost-effective option for treating DVT and PE and preventing further episodes in adults."
Sanofi CEO, Christopher Viehbacher commented: "We are pleased with our performance in the third quarter. We achieved solid Business EPS growth driven by continued strong contribution from our growth platforms, allowing us to confirm 2014 outlook. Growth platforms reached over 78% of sales and grew 10%. We have recently seen a more challenging US diabetes price environment which will impact our diabetes sales throughout 2015, while growth platforms globally are expected to continue to show solid growth. At the same time, our pipeline delivered strong results, with the release of exciting Phase III data for alirocumab and our Dengue vaccine, the entry of dupilumab in Phase III as well as the FDA approval of Cerdelga and the licensing of Afrezza."
...sees value in combining his group's clinical know-how with LLR's research chops and is pushing for nonprofits to pool their resources more often. "We hope this will pave the way for further strategic partnerships with other charities who are interested in working together to speed up the translation of today's scientific discoveries into future cancer treatments" Blackburn said in a statement. - read the release

More Content

All (2364) | News (1838) | Reports (0) | Blogs (417) | Audio/Video (2) | Fact Sheets (32) | Press Releases (69)
sort by: Date | Relevance
CEO Chris Viehbacher ousted from Sanofi [Published Raleigh News & Observer - 24 mins ago]
Therapeutic Focus 2014: Neurology [Published Medical Marketing And Media - 28 mins ago]
Tourbillion Wins Shorting MannKind Corporation,... [Published Value Walk - 1 hour ago]
Deal-Starved Perrigo Company In Exclusive Talks... [Published BioSpace - 1 hour ago]
Off With Their Heads! s Favorite CEOs Who Got ... [Published BioSpace - 1 hour ago]
Industry, academia unite in GPCR Consortium [Published Drug Discovery News - 1 hour ago]
First nationwide health study in decades ‘SAĦĦT... [Published di-ve.com - 1 hour ago]
NICE recommends new indication for troubled Pra... [Published Pharmafocus - 1 hour ago]
East Cost Biotech Roundup: Sarepta, Aegerion, S... [Published Xconomy - 2 hours ago]
Global Analysis on Ketoprofen Market and Foreca... [Published MyNewsDesk - 2 hours ago]
New Genital Herpes vaccine entrants require imp... [Published European Pharmaceutical Review - 2 hours ago]
Sanofi chairman to roll sleeves up again [Published FT.com - Companies, Europe - 2 hours ago]
Financial Results, Acquisition Agreement, and L... [Published Rock Hill Herald - 2 hours ago]
Financial Results, Acquisition Agreement, and L... [Published Industrial Info Financials - 2 hours ago]
Financial Results, Acquisition Agreement, and L... [Published Financial Services - 2 hours ago]
Sanofi Q3 net income decreases [Published Individual.com - 3 hours ago]
Potential Sanofi (SNY) Trade Targets 2.62% Return [Published MarketIntelligenceCenter.com - 3 hours ago]
Swedish Skanksa opens its first office building... [Published Romania Business Insider - 3 hours ago]
Mycosis Fungoides and Leiomyosarcoma - Cancer T... [Published Market Pulse Navigator - 3 hours ago]
Perrigo Beats Competition To Enter Into Exclusi... [Published Bidness Etc - 4 hours ago]
French Market Advances, BNP Paribas Up On Earnings [Published RTTNews.com - 5 hours ago]
Perrigo in exclusive talks to acquire Omega Pha... [Published Crains Detroit Business - 5 hours ago]
World Diabetes Day Activities organised by the ... [Published di-ve.com - 6 hours ago]
Research and Markets: Global Pediatric Vaccine ... [Published Digital Journal - 6 hours ago]
Research and Markets: Global Pediatric Vaccine ... [Published Business Wire Health News - 6 hours ago]
Global Pediatric Vaccine Market 2014-2018: Key ... [Published Individual.com - 6 hours ago]
Firm warns Nigerians against fake imported drugs [Published Nigeria Punch - 13 hours ago]
Benzinga's M&A Chatter for Thursday October 30,... [Published Benzinga.com - 13 hours ago]
Sanofi SA Cut to Hold at Deutsche Bank (SNY) [Published Mideast Time - 14 hours ago]
Big Pharma backs EU antibiotic R&D plan, Pfizer... [Published FierceBiotech - 17 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Potential Sanofi (SNY) Trade Targets 2.62% Return [Published MarketIntelligenceCenter.com - 3 hours ago]
The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered-call trade on Sanofi-Aventis (SNY) that includes 4.05% downside protection. Sell one contract of the Dec. '14 ...
Research and Markets: Global Pediatric Vaccine ... [Published Business Wire Health News - 6 hours ago]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/tgvqjr/global_pediatric) has announced the addition of the "Global Pediatric Vaccine Market 2014-2018" report to their offering. Pediatric vaccines are used for ...
French companies: Room at the top [Published The Economist - Business - Oct 30 2014]
Adieu, Monsieur ViehbacherTHE once-familiar line-up of bosses at France’s largest firms is getting less familiar all the time, as one after another is moved, fired or quits. This week it was the turn of Christopher Viehbacher, the German-Canadian chief ...
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossma... [Published PR Newswire: Financial Services - Oct 30 2014]
NEW YORK, Oct. 30, 2014 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Sanofi. ("Sanofi" or the "Company") (NYSE: SNY -News).  Such investors ...
Sanofi (SNY) Showing Resistance Near $46.37 [Published MarketIntelligenceCenter.com - Oct 30 2014]
After Wednesday’s trading in Sanofi-Aventis (SNY) the algorithms behind MarketIntelligenceCenter.com's Artifical Intelligence Center picked out a trade that offers a 3.16% or 22.64% (for comparison purposes only), while providing 3.54% downside protection. ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Sanofi takes aim at dengue fever [Published Reuters Video: Top News - Jul 11 2014]
Sanofi takes aim at dengue fever [Published Reuters Video: Business - Jul 11 2014]
1

Press Releases

sort by: Date | Relevance
Financial Results, Acquisition Agreement, and L... [Published Financial Services - 2 hours ago]
Statement from Sanofi Board of Directors [Published GlobeNewswire: Advertising News - Oct 29 2014]
Statement from Sanofi Board of Directors [Published Sanofi.com - Last press releases - Oct 29 2014]
Zealand reports Lyxumia® royalty revenue for th... [Published GlobeNewswire: Acquisitions News - Oct 28 2014]
Sanofi delivers Business EPS growth of 10.3% at... [Published Sanofi.com - Last press releases - Oct 28 2014]
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.